WallStreetZenWallStreetZen

NASDAQ: SPRC
Scisparc Ltd Stock

$1.12+0.02 (+1.82%)
Updated May 29, 2024
SPRC Price
$1.12
Fair Value Price
N/A
Market Cap
$791.49k
52 Week Low
$1.10
52 Week High
$23.66
P/E
-0.29x
P/B
0.39x
P/S
1.74x
PEG
N/A
Dividend Yield
N/A
Revenue
$767.73k
Earnings
$1.41M
Gross Margin
76.3%
Operating Margin
215.32%
Profit Margin
177.9%
Debt to Equity
0.21
Operating Cash Flow
-$2M
Beta
0.36
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SPRC Overview

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SPRC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SPRC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SPRC is good value based on its book value relative to its share price (0.39x), compared to the US Biotechnology industry average (5.94x)
P/B vs Industry Valuation
SPRC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SPRC due diligence checks available for Premium users.

Be the first to know about important SPRC news, forecast changes, insider trades & much more!

SPRC News

Valuation

SPRC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.29x
Industry
15.85x
Market
31x

SPRC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.39x
Industry
5.94x
SPRC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SPRC's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
SPRC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SPRC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.1M
Liabilities
$439.4k
Debt to equity
0.21
SPRC's short-term assets ($1.72M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SPRC's short-term assets ($1.72M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SPRC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SPRC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
SPRC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SPRC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SPRC$791.49k+1.82%-0.29x0.39x
VRPX$855.00k+2.67%-0.05x-0.70x
GRI$1.23M+3.17%0.02x0.44x
ATNF$1.49M-2.47%-0.05x-1.56x
DRMA$1.53M+5.29%-0.12x0.40x

Scisparc Stock FAQ

What is Scisparc's quote symbol?

(NASDAQ: SPRC) Scisparc trades on the NASDAQ under the ticker symbol SPRC. Scisparc stock quotes can also be displayed as NASDAQ: SPRC.

If you're new to stock investing, here's how to buy Scisparc stock.

What is the 52 week high and low for Scisparc (NASDAQ: SPRC)?

(NASDAQ: SPRC) Scisparc's 52-week high was $23.66, and its 52-week low was $1.10. It is currently -95.27% from its 52-week high and 1.82% from its 52-week low.

How much is Scisparc stock worth today?

(NASDAQ: SPRC) Scisparc currently has 706,683 outstanding shares. With Scisparc stock trading at $1.12 per share, the total value of Scisparc stock (market capitalization) is $791.49k.

Scisparc stock was originally listed at a price of $16,343.60 in Mar 22, 2017. If you had invested in Scisparc stock at $16,343.60, your return over the last 7 years would have been -99.99%, for an annualized return of -74.58% (not including any dividends or dividend reinvestments).

How much is Scisparc's stock price per share?

(NASDAQ: SPRC) Scisparc stock price per share is $1.12 today (as of May 29, 2024).

What is Scisparc's Market Cap?

(NASDAQ: SPRC) Scisparc's market cap is $791.49k, as of May 30, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Scisparc's market cap is calculated by multiplying SPRC's current stock price of $1.12 by SPRC's total outstanding shares of 706,683.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.